Larvol Delta - Design-of-the-Phase-2-ALANIS-Study-Belantamab-Mafodotin-in-Combination-with-Bortezomib-Cyclophosphamide-and-Dexamethasone-Vcd-in-Patients-with-Newly-Diagnosed-Amyloid-Light-Chain-Amyloidosis

Blenrep (belantamab mafodotin-blmf) - GSK

bortezomib - Generic mfg.

cyclophosphamide - Generic mfg.

https://imsannual2026.eventscribe.net/ajaxcalls/PosterInfo.asp?efp=TU1XRFNPTlIyMjY0Nw&PosterID=826672&rnd=0.6724276

Efstathios Kastritis, MD, PhD

Sep 11, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next